FAK is a non-receptor tyrosine kinase contributing to migration and proliferation downstream of integrin and/or growth factor receptor signaling of normal and malignant cells. In addition to well-characterized tyrosine phosphorylations, FAK is phosphorylated on several serines, whose role is not yet clarified. We observed that phosphorylated FAK on serine 732 (P-FAKSer732) is present at variable levels in vitro, in several melanoma, ovarian and thyroid tumor cell lines and in vivo, in tumor cells present in fresh ovarian cancer ascites. In vitro P-FAKSer732 was barely detectable during interphase while its levels strongly increased in mitotic cells upon activation of the EGFR/MEK/ERK axis in an integrin-independent manner. P-FAKSer732 presence was crucial for the maintenance of the proliferation rate and its levels were inversely related to the levels of acetylated a-tubulin. P-FAKSer732 localized at the microtubules (MTs) of the spindle, biochemically associated with MTs and contributed to MT depolymerization. The lack of the phosphorylation on Ser732 as well as the inhibition of CDK5 activity by roscovitine impaired mitotic spindle assembly and correct chromosome alignment during mitosis. We also identified, for the first time, that the EGF-dependent EGFR activation led to increased P-FAKSer732 and polymerized MTs. Our data shed light on the multifunctional roles of FAK in neoplastic cells, being involved not only in integrin-dependent migratory signaling but also in integrin-independent MT dynamics and mitosis control. These findings provide a new potential target for inhibiting the growth of tumor cells in which the EGFR/MEK/ERK/CDK5 pathway is active. Subject Category: Cancer FAK, a ubiquitously expressed non-receptor tyrosine protein kinase, has a key role in regulating signals at sites of cell extracellular matrix adhesion through integrins and at activated growth factor receptors.
FAK is a non-receptor tyrosine kinase contributing to migration and proliferation downstream of integrin and/or growth factor receptor signaling of normal and malignant cells. In addition to well-characterized tyrosine phosphorylations, FAK is phosphorylated on several serines, whose role is not yet clarified. We observed that phosphorylated FAK on serine 732 (P-FAKSer732) is present at variable levels in vitro, in several melanoma, ovarian and thyroid tumor cell lines and in vivo, in tumor cells present in fresh ovarian cancer ascites. In vitro P-FAKSer732 was barely detectable during interphase while its levels strongly increased in mitotic cells upon activation of the EGFR/MEK/ERK axis in an integrin-independent manner. P-FAKSer732 presence was crucial for the maintenance of the proliferation rate and its levels were inversely related to the levels of acetylated a-tubulin. P-FAKSer732 localized at the microtubules (MTs) of the spindle, biochemically associated with MTs and contributed to MT depolymerization. The lack of the phosphorylation on Ser732 as well as the inhibition of CDK5 activity by roscovitine impaired mitotic spindle assembly and correct chromosome alignment during mitosis. We also identified, for the first time, that the EGF-dependent EGFR activation led to increased P-FAKSer732 and polymerized MTs. Our data shed light on the multifunctional roles of FAK in neoplastic cells, being involved not only in integrin-dependent migratory signaling but also in integrin-independent MT dynamics and mitosis control. These findings provide a new potential target for inhibiting the growth of tumor cells in which the EGFR/MEK/ERK/CDK5 pathway is active. Subject Category: Cancer FAK, a ubiquitously expressed non-receptor tyrosine protein kinase, has a key role in regulating signals at sites of cell extracellular matrix adhesion through integrins and at activated growth factor receptors. 1 Integrin-dependent activated FAK is recruited to focal adhesions (FAs) and promotes dynamic actin and adhesion changes at the membrane and signaling to proliferation and to survival pathways. FAK expression is required for many normal cellular functions in development and angiogenesis, 2, 3 and its expression is upregulated in a variety of late-stage cancers. 4 Through different molecular connections, FAK can influence cell movement regulating cytoskeleton remodeling, FA turnover and membrane protrusions. 1 FAK also seems to affect cell proliferation by regulating cell cycle progression from G1 to S phases by increasing the expression of cyclin D1. 5, 6 For all these reasons, FAK expression and activation has been linked to cell transformation and metastasis.
The overall molecular structure of FAK is also consistent with its function as a protein scaffold. The amino-terminal tyrosine (Tyr) 397 residue of FAK, whose autophosphorylation leads to full FAK activation, creates a high-affinity binding site recognized by the SH2 domain of the Src family. 7 Src binding promotes FAK phosphorylation within the kinase domain activation loop at Tyr576 and Tyr577, which are necessary for maximal FAK-associated activity. 1 The carboxyl-terminal domain FAK-related non-kinase (FRNK) is a truncated isoform of FAK expressed in selected cellular types. 8 FRNK lacks the Tyr397, thus acting as a dominant negative isoform of FAK. FRNK inhibits both integrinand growth factor-induced FAK activation and blocks FAK-mediated cell migration and proliferation. 9 The COOH-terminal domain of FAK undergoes several serine (Ser) phosphorylation events whose role is not well understood. In neocortical neurons, phosphorylation of FAK at Ser732 (P-FAKSer732), by the post-mitotic cyclin-dependent kinase (CDK) 5, regulates microtubule (MT) stability and migration by pulling the proximal region of the nucleus into the leading process, likely in the direction of the centrosome. 10, 11 In endothelial cells (ECs), P-FAKSer732, phosphorylated by Rho-associated protein kinase (ROCK), 12 has been found co-localized with g-tubulin at the centrosomes; deletion of FAK in primary ECs causes an increase in centrosome numbers, and multipolar and disorganized spindles. 13 P-FAKSer732 has been characterized mainly in normal cells. 10, 12, 13 Here, we aimed to analyze in detail the presence and the role of P-FAKSer732 in tumor cells.
Results P-FAKSer732 is detected in tumor cells and is not localized at the FAs during migration. The presence of P-FAKSer732 was analyzed together with that of -Tyr576, the site responsible for maximal FAK activity, in melanoma, ovarian and thyroid cancer cells. Basically, in all cell lines the expression of FAK was also associated with the presence of P-FAKSer732 and -Tyr576, although at variable levels ( Figure 1a) . FAK was mainly phosphorylated on Ser732 in Me#21 and #25. High expression of FAK, P-FAKSer732 and -Tyr576 was also observed in Me#20, a primary tumor and in Me#31, a visceral metastases. All these melanoma cell lines, which also express the highest levels of FAK, belong to a subset of melanomas lacking the melanocyte transcription factor MITF and melanoma differentiation antigens. 14 Three out of eight ovarian carcinomas and one out of three thyroid cell lines expressed FAK, P-FAKSer732 and -Tyr576 at high levels. In the lysates from tumor cells contained in fresh ascites from advanced stage ovarian cancer (Supplementary Table S1 ), FAK was also found phosphorylated on Ser732 (Figure 1b) , indicating that this phosphorylation is not restricted to cells cultured in vitro.
The melanoma Me#28 cell line was further characterized, and, for selected experiments, the ovarian carcinoma OAW42 and the thyroid carcinoma NIM-1 cell lines were also analyzed.
In tumor cells, FAK regulates cell motility by directing cell migration. During migration, phosphorylated FAK at tyrosine residues localizes at the FAs and/or at the front and the rear of the cells. 1 Indeed, transient knockdown of FAK through specific siRNA in Me#28 cells induced a statistically significant decrease of wound repair compared with cells transfected with a non-silencing siRNA both at 24 h and at 30 h (Figure 1c ), when the latter had completely repaired the wound. Immunofluorescence (IF) was used to analyze the localization of FAK phosphorylated isoforms in Me#28 cells migrating into the wound. P-FAKSer732 localized in the cytoplasm and in a perinuclear region but not at FAs (Figure 1d ), whereas both P-FAKTyr397 and -Tyr576 were detected in the cytoplasm and at FAs of the leading edge. In addition, western blot analysis of Me#28 samples following immunoprecipitation (IP) with anti-P-FAKSer732 antibody (Ab) indicated that the principal form in the immunoprecipitate consisted of FAK phosphorylated on Ser732 (Figure 1e ), whereas the dominant form in the unbound fraction contained mainly P-FAKTyr576.
These results demonstrate that FAK exists as two distinct pools: the first associated with FAs and the second, phosphorylated on Ser732, localized in the cytoplasm in a perinuclear region.
FAK is phosphorylated at Ser732 independently from integrin engagement. To investigate whether the Ser732 phosphorylation was consequent to that at Tyr397, Me#28 cells were stably transfected with FRNK construct and the FRNK-expressing clone F6 was selected by western blotting (Figure 2a To assess whether the phosphorylation at Ser732 was dependent on integrin engagement and activation, Me#28 cells were grown in absence of FCS for 24 h on plastic or fibronectin. Western blotting on cell lysates showed that P-FAKSer732 was not increased in cells grown onto fibronectin (Figure 2c ), while P-FAKTyr397 and -Tyr576 increased, as expected, in cells grown on fibronectin indicating that P-FAKSer732 is not a downstream effector of integrin activation.
These results indicate that phosphorylation at Ser732 is independent of FAK autophosphorylation at Tyr397, while the latter is necessary for phosphorylation at Tyr576 upon integrin engagement, as already demonstrated. 15 P-FAKSer732 accumulates in mitotic cells and co-localizes with MTs of the mitotic spindle. Then, we asked whether proliferative stimuli could induce P-FAKSer732. Indeed, FCS stimulation of starved Me#28, OAW42 and NIM-1 cell lines, induced, in all of them, increased levels of P-FAKSer732 (Figure 3a ) that highly accumulated, as shown by IF in Figure 3b , in mitotic cells. In cells in interphase, P-FAKSer732 did not accumulate and was located in the cytoplasm, as already shown in Figure 1e .
Confocal IF was performed to better investigate on P-FAKSer732 localization in dividing Me#28 cells. P-FAKSer732 co-localized with a-tubulin at the mitotic spindle during metaphase ( Figure 3c , left panel). During late anaphase, P-FAKSer732 co-localized with a-tubulin at the spindle, likely at the sites where MTs elongate and shrink ( Figure 3c , middle panel), and accumulated in the middle of the spindle, indicating an interaction with the cortical actin. Anti-P-FAKSer732 also diffusely stained the cell cytoplasm, but no co-localization with g-tubulin at the centrosome was observed ( Figure 3c , right panel). Furthermore, P-FAKSer732 co-localized with ac-a-tubulin of the spindle in all mitotic phases upon extraction of soluble tubulin (Figure 3d ).
The MT motor protein dynein regulates MT dynamics and cortical pulling forces at the spindle poles. 16 To biochemically analyze the possible association between FAK, observed mainly at the MTs of the spindle, and dynein, an IP was performed on Me#28 lysates with anti-P- Therefore, P-FAKSer732 associates with polymerized MTs of the spindle during all mitotic stages and is biochemically linked to dynein arguing for the notion of a role during mitosis.
FAK contributes to cell proliferation when it is phosphorylated at Ser732. To assess a role of P-FAKSer732 in proliferation, Me#28 cells were treated with a specific siRNA against FAK and growth capability was assayed. The growth rate of melanoma cells decreased 25% after 48 h and up to 40% after 72 h (Figure 4a ). Furthermore, phosphorylation on Ser10 of Histone H3 (herein named PHH3), a marker of mitosis, 17 was 30% lower in FAK-silenced cells in comparison with cells transfected with a control siRNA (Figure 4b ), suggesting a role of FAK in the control of the mitosis.
To specifically assess a role of P-FAKSer732 in cell proliferation, we transiently transfected, in control or FAKsilenced Me#28 cells, a GFP construct alone, or containing the wild-type (wt) GFP-FAK or a mutated FAK on Ser732-Ala 10 (herein named Mut GFP-FAK). Control silenced cells transfected with Mut GFP-FAK displayed a 53% growth rate reduction in comparison with those transfected with wt GFP-FAK (Figure 4c ). Growth reduction reached 70% when Mut GFP-FAK was transfected into FAK-silenced cells. The re-expression of wt GFP-FAK in FAK-silenced cells was not able to return proliferation to that observed in control-siRNAtreated cells although a 30% increase was observed respect to siFAK-treated cells transfected with GFP only. These data argue for the hypothesis that a delicate balance between total FAK and P-FAKSer732 is necessary to maintain the correct growth rate.
The above reported results were further confirmed by western blotting of cell lysates from the transfectants described above. Both wt and Mut GFP-FAK-transfected cells showed a decrease of PHH3 (Figure 4d ), indicating a role in the entry in mitosis. Conversely, expression of the Mut GFP-FAK increased the amount of polymerized MTs, evaluated with anti-acetylated a-tubulin (ac-a-tubulin) Ab.
These data strongly indicate that P-FAKSer732 is associated to an increased growth potential and, together with the results shown above, also argue for the hypothesis of 
P-FAKSer732 contributes to MT depolymerization.
To investigate whether the effect on MTs, analyzed as ac-a-tubulin, could only be due to P-FAKSer732, NIM-1 cells, that express low levels of FAK (Figure 1a ), were transfected with the construct expressing wt and Mut GFP-FAK. Western blot analysis of cell lysates showed that cells transfected with Mut GFP-FAK contained about 2.5-fold more ac-a-tubulin compared with cells transfected with wt GFP-FAK (Figure 5a ). Conversely, iper-expression of FAK, as in wt GFP-FAK-transfected cells, was associated to 50% decrease of ac-a-tubulin respect to GFP-transfected cells.
The fact that the amount of polymerized MTs was inversely related to the amount of P-FAKSer732 argues for the hypothesis that FAK can modulate MT dynamics. To test this possibility, we performed a MT re-growth assay on Me#28 and OAW42 cells upon FAK silencing. Silenced cells were treated overnight (o.n.) with nocodazole to force MT depolymerization, evaluated as the absence of ac-a-tubulin, and then MT re-growth was analyzed after nocodazole washout. FAK-silenced cells showed a higher amount of ac-a-tubulin indicating higher levels of polymerized MTs and, after nocodazole treatment, ac-a-tubulin was slightly detected. Of note, the knockdown of FAK induced a better rescue of MT re-growth after nocodazole removal compared with cells transfected with control siRNA (Figure 5b) .
These data strongly indicate that FAK phosphorylated at Ser732 has a role in MT depolymerization.
Lack of Ser732 phosphorylation impairs spindle assembly and mitosis. To specifically evaluate the role of P-FAKSer732 during mitosis, wt and Mut GFP-FAK were transiently transfected in Me#28 and NIM-1 cells. In interphase, wt (Figure 6a, left panel) and Mut GFP-FAK (Figure 6b , left panel) were mainly localized at the sites of the FAs, and no differences were observed between the two transfectants. In mitotic cells, Mut GFP-FAK localized in randomly positioned spindle showing a diffused staining along the entire spindle and the chromosomes appeared significantly unaligned (Figure 6b, right panel) . wt GFP-FAKtransfected cells showed a regular spindle with wt GFP-FAK mainly localized on polar MTs (Figure 6a, right panel) . In agreement with these results, the number of mitosis was six-and threefold lower in Mut GFP-FAK-transfected Me#28 and NIM-1 cells (Figure 6c ).
The MEK/ERK pathway is involved in the phosphorylation at Ser732 associated with polymerized MTs. Several solid tumors have a hyper-activated MEK/ERK pathway and ERK was already proposed to be a regulator of MT dynamics and mitosis. 18, 19 Thus, a possible involvement of MEK/ERK and Rho/ROCK pathways, which generates P-FAKSer732 in ECs, 12 was analyzed upon treatment with UO126 and Y27632, which are inhibitors of MEK and ROCK, respectively. In FCS-stimulated Me#28 cells, UO126 inhibited P-FAKSer732 nearly 90% and Y27632 reduced P-FAKSer732 up to 30% (Figure 7a ). As FAK can be an up-and a downstream effector of both MEK/ERK and Rho/ROCK pathways, 20 the effects of FAK expression on these pathways was analyzed. Transient FAK silencing in Me#28 cells induced 35% reduction of ERK phosphorylation (Figure 7b As shown above, UO126 completely inhibited P-FAKSer732. These results strongly indicate that MEK/ERK pathway is responsible for P-FAKSer732. Obserivng the relationship among P-FAKSer732, MEK/ ERK activation and polymerized tubulin (Figures 4 and 5) , we assessed whether MEK/ERK inhibitor was able to modulate the amount of polymerized tubulin. UO126 treatment on Me#28 and OAW42 cells increased the amount of ac-a-tubulin and decreased the amount of P-FAKSer732 in a dosedependent manner, indicating an inverse correlation between FAK, phosphorylated on Ser732 by MEK/ERK and MT polymerization (Figure 7c) .
The biochemical association of P-FAKSer732 with polymerized MTs was then investigated by western blotting on cell extracts upon separation of soluble and polymerized a-tubulin fractions. P-FAKSer732 was found in both soluble and MT fractions, but UO126 treatment decreased the levels of P-FASer732 in the MT fraction only (Figure 7d ), indicating that a part of P-FAKSer732 is associated with ac-a-tubulin and that de novo phosphorylation on Ser732 of FAK occurs at the level of MTs. Ac-a-tubulin of MT fraction increased in UO126-treated cells. 21 and CDK5 phosphorylates FAK on Ser732 in neural cells. 11 To test the hypothesis that P-FAKSer732 is induced by EGFR/CDK5 pathway activation, starved Me#28, NIM-1 and OAW42 cells were stimulated with EGF. In all the three cell lines, EGF stimulation increased P-ERK together with P-FAKSer732 and P-CDK5Tyr15, the active kinase isoform (Figure 8a ). To test whether CDK5 was downstream of EGFR/MEK/ERK signaling cascade, ERK2 siRNA-treated Me#28 cells were stimulated with EGF. EGF stimulation strongly decreased P-FAKSer732 and P-CDK5Tyr15 of ERK2-silenced cells but not of control siRNA-treated cells (Figure 8b ). To confirm the presence of the axis MEK/ERK/ CDK5/P-FAKSer732, starved Me#28, OAW42 and NIM-1 cells were treated with increasing concentrations of roscovitine, a potent CDK5 inhibitor. 22 Roscovitine treatment decreased the amount of P-FAKSer732 in a dose-dependent manner in all cell lines (Figure 8c ), but did not affect the level of P-FAKTyr397 and of P-ERK. Moreover, roscovitine treatment increased the amount of ac-a-tubulin in a dosedependent manner.
EGF-dependent EGFR/MEK/ERK/CDK5 pathway induces P-FAKSer732, thus contributing to mitosis. MEK/ERK pathway is one of the downstream effector of EGFR
IF on roscovitine-treated NIM-1 cells showed impaired spindle (Figure 8d ), according to the data reported in Figure 6 . P-FAKSer732 staining was lower and diffused with respect to that observed on FCS-treated cells, and no co-localization with acetylated a-tubulin was observed.
These data strongly indicate that EGFR/MEK/ERK/CDK5 pathway induces the phosphorylation of FAK at Ser732 independently from the FAK autophosphorylation, thus contributing to spindle formation and mitosis of tumor cells.
Discussion
We present here a deep analysis on the role of FAK phosphorylated on Ser 732 in tumor cells. We have found that the phosphorylation of FAK at Ser732 occurs independently from integrin activation, is not localized at the sites of FAs and accumulates in mitotic cells strongly suggesting that, regardless of FAK involvement in migration, P-FAKSer732 has a role in mitosis, thus regulating the proliferation of tumor cells. P-FAKSer732 appears to control mitotic spindle assembly and correct chromosome segregation. Hence, FAK can exert in tumor cells a dual role: one, fully described elsewhere, integrin-dependent associated to phosphorylation of Tyr397 and -576 with a role in migration, and the other, characterized here for the first time, integrin-independent associated to phosphorylation on Ser732 upon activation of the EGFR/MEK/ERK/CDK5 pathway, regulating MT dynamics. Although P-FAKSer732 was already observed in neural and in few non-neural cells, that is, Cos, HeLa cells and ECs, phosphorylated by CDK5, 10, 13 our results clearly increase the knowledge about the role of FAK phosphorylated on Ser732 focusing in tumor cells. While in migrating neural cells P-FAKSer732 was shown to be responsible for the MT assembly to generate forces for nuclear movement, in ECs P-FAKSer732 associated to the centrosomes was related to centrosome function during mitosis. On the contrary, we found P-FAKSer732 localized at the mitotic spindle and not at the centrosomes indicating that P-FAKSer732 exerts, in the analyzed tumor cells, a role at the level of the spindle MTs. Indeed, we also gave evidences of an inverse relationship between P-FAKSer732 and ac-a-tubulin, and the MT re-growth assay clearly showed that the lack of FAK expression delayed MT polymerization, strongly indicating for the first time a role of FAK in MT dynamics.
Dynein is a minus-end MT motor protein that contribute to the generation of forces necessary to keep the spindle pole at the correct distance from the equator. 23 On the other hand, different actin structures and actin-associated proteins contribute to spindle orientation through the anchorage of astral MTs. 24 The localization of P-FAKSer732 at both MTs of the spindle and cortical ring as well as the association with dynein suggest a role of P-FAKSer732 as molecular cue for correct MT dynamics, spindle assembly and/or correct chromosome segregation. Further studies will be required to elucidate the involvement of FAK during mitotic spindle assembly and positioning.
In solid tumors, one of the hallmarks is the chromosome instability caused by wrong chromosome segregation. The alteration of MT dynamics is one of the causes of the chromosomal instability. 25 In this context, P-FAKSer732 seems to participate to MT depolymerization, thus maintaining normal spindle assembly and function. However, as already observed for MCAK, the mitotic centromere-associated kinesin, 26 the phosphorylation of FAK at the Ser732 could be finely orchestrated by kinases and phosphatases specifically activated in tumor cells. Therefore, future attention should be paid to analyze, in a wide panel of tumor biopsies, as well as in their normal counterparts, the relationship between the presence of P-FAKSer732 and the clinical outcome or sensitivity to conventional therapies. In addition, our data also suggests that the activation of the identified signaling pathway could be preferentially activated in different tumor subsets. Indeed, melanoma cell lines displaying the highest levels of P-FAKSer732 belong to a tumor subgroup lacking MITF and melanoma differentiation antigens such as MART-1 and gp100.
14 The presence of P-FAKSer732 in ovarian carcinoma cells from ascites further supports a correlation between this particular FAK phosphorylation and malignant cells with high proliferative capability in vivo. These data indicate that the analysis of the involvement of FAK in the mitotic spindle assembly and function in tumor cells appear to be instrumental for developing specific inhibitors to this particular FAK function in malignant cells.
We also showed that P-FAKSer732 was generated by the activation of the EGFR/MEK//ERK/CDK5 signaling. In neural cells, CDK5 is considered a post-mitotic kinase whose activation is dependent on the expression of CDK activators p35 and p39. 27 In tumors, p35-dependent activation of CDK5 appeared to occur following ERK activation, which in turn led to increased Egr1 transcriptional activity and upregulation of p35 expression. 28 In pancreatic cancer, inhibition of CDK5 kinase activity was found to suppress ras signaling, 29 indicating a possible relationship between MEK/ERK and CDK5 activations. As we have clearly shown here that the MEK/ERK pathway activation and the activated P-CDK5Tyr15 are associated with the generation of P-FAKSer732, at least in the analyzed tumor cells, the induction of p35 or p39 expression can be hypothesized. Several years ago, Harrison and Turley 18 showed in H-ras-transformed cells that ERK associated with the MTs of the mitotic spindle, thus regulating their stability. Based on our results, we hypothesize that those observations were not due to ERK itself, but due to FAK upon phosphorylation at Ser732 caused likely by CDK5. Analysis of CDK5 expression and activation as well as p35 and p39 expression await further investigation in tumor cells especially when the ras/RAF/MEK/ERK is constitutively activated by mutations.
Although ROCK does not appear to phosphorylate FAK on Ser732, as suggested previously, 12 we cannot exclude involvement of Rho/ROCK pathway in the activation of the signaling circuit MEK/ERK/FAK/ERK. This hypothesis is not weird, as the Rho/ROCK pathway regulates actin dynamics through cofillin 30 and spindle orientation is regulated by cortical actin. 24 Experiments are ongoing to better clarify the mechanism that links Rho/ROCK pathway and P-FAKSer732.
The link between EGFR activation and P-FAKSer732, never demonstrated before for tumor cells, might be considered an important step forward in understanding EGFR function in tumors. Further knowledge may be useful to design alternative therapeutic approach, especially in tumors that become resistant to anti-EGFR compounds. Cells. Human melanoma cell lines were obtained from surgical specimens of patients admitted to INT. These cells have been extensively characterized as reported elsewhere.
14 Nine human ovarian cancer cell lines were used in this study: IGROV-1 kindly provided by Dr. Bénard 33 and maintained in DMEM supplemented with 10% FCS and 1% L-glutamine in a humidified atmosphere of 5% CO 2 . The human thyroid cell lines NIM-1, 34 TPC1 and BCPAP 35 were maintained in DMEM supplemented with 10% FCS and 1% L-glutamine in a humidified atmosphere of 5% CO 2 in air. Ascites from patients with stage III ovarian cancer were collected at the time of debulking surgery. Cytological analysis confirmed that the ascites mainly contained tumor cells, as also demonstrated by the expression of the epithelial marker E-cadherin. The features of ovarian carcinoma specimens are listed in Supplementary Table S1 . UO126, Y27632 and roscovitine treatment were performed o.n. on starved cells before the relevant stimulation.
Stable transfection. Me#28 cells were placed on 96-well dishes and transfected after 24 h with 0.2 mg per well of the FRNK-containing vector (kindly provided by Dr. Ungefrorer, Hamburg) and pcDNA3.1 (Invitrogen), as mocktransfected vector, using Lipofectamine 2000 reagent following the manufacturer's protocol. At 48 h after the transfection, G418-containing media was added and changed every 48-72 h thereafter to generate stable transfectants. After 2 weeks, isolated colonies were analyzed by western blotting for the presence of FRNK (41 kDa) in total cell lysates using the anti-carboxyl-terminal domain of FAK.
Cell growth on fibronectin. Fibronectin-coated 12-well coated plate was prepared with a 2 mg/ml fibronectin solution in RPMI and incubated (o.n.) at 37 1C. The next day, cells (0.8 Â 10 5 /well) were plated in serum-free condition on plastic or fibronectin for 20 min. Western blotting was performed on total lysates as described below.
Western blotting and IP. Cells were washed with ice-cold PBS containing Na 3 VO 4 (0.1 mM) and lysated with NuPAGE LDS sample buffer (1 Â ) (Invitrogen) under reducing conditions. Proteins were separated on precast 4-12% SDSpolyacrylamide gels (Invitrogen). Western blot was performed as described 36 and analyzed using ChemiDoc XRS System and the Quantity One software (Bio-Rad, Hercules, CA, USA). The relevant values were always normalized with the values of the protein used as control of gel loading.
The separation of soluble and polymerized tubulin has been described elsewhere. 37 In some experiments, cells were grown in standard medium o.n., washed twice in PEM buffer (100 mM PIPES pH 6.9, 1 mM EGTA, 2 mM MgCl 2 ) and then cells were incubated in PEM buffer containing 0.2% Triton X-100 for 1 min at 37 1C and then rinsed and incubated in PEM buffer at 37 1C for 5 min. Cells were lysed as described above.
IP was performed essentially as described. 36 Briefly, cells were lysed in cold lysis buffer (150 mM NaCl, 50 mM Tris-HCl, pH 7.4, 0.25% NaDoc, 1 mM EDTA pH 8, 1 mM Na 3 VO 4 , 1% PMSF, 1% NP-40 and protease inhibitors) for 30 min on ice. Cellular debris and nuclei were removed by centrifugation at 13 000 r.p.m./min for 30 min at 4 1C. Normal rabbit or mouse sera were used as negative control. Primary Ab was bound to beads conjugated with goat anti-mouse or -rabbit Ab (Dynabeads; Dynal ASA, Oslo, Norway) and incubated with cell extracts o.n. at 4 1C with rotation. Beads were washed once with cold lysis buffer, twice with PBS plus BSA and protease inhibitors, and once with PBS plus inhibitor (10 min/wash). Immunoprecitated proteins were separated on 4-12% SDS-PAGE under reducing conditions. siRNA treatment and transient transfection. siRNA transfections were performed using Lipofectamine 2000 according to the manufacturer's protocol. For FAK silencing, 40 pmol/ml small-interfering RNA (siRNA) duplex specific for FAK (Smart Pool, Thermo Scientific, Dharmacon, Inc. Chicago, IL, USA) or control siRNA (Qiagen-Xeragon, Germantown, MD, USA) were applied. Total cell lysates were prepared 48 h after transfection. Otherwise, 24 h after siRNAs treatment, transfected cells were placed on six-well dishes and transfected with 2 mg of GFP, wt GFP-and Mut GFP-FAK vectors 10 using Lipofectamine 2000 reagent (Invitrogen), following the manufacturer's protocol. In some experiments, cells were transfected with wt and Mut GFP-FAK vectors without FAK silencing.
For ERK2 silencing, 40 pmol/ml siRNA duplex specific for MAPK1(Smart Pool, Thermo Scientific, Dharmacon, Inc.) or control siRNA (Qiagen-Xeragon) were applied. Treatment with EGF (20 ng/ml) was carried out 24 h after transfection in a serum-free medium. Total cell lysates were prepared 48 h after transfection.
Wound-healing assay. Confluent cultures of Me#28 transfected with FAK siRNA or control siRNA were wounded using a sterile 200-ml pipette tip. Wound closure was assessed 4, 24 and 30 h later with an inverted microscope with a Â 10, 0.75 NA PanFluor objective (Nikon, Tokyo, Japan). Images were acquired with ACT-1 software (Nikon) at a resolution of 1280 Â 1024 pixels. The wound closure was measured on 10 different micrographs captured in three wells for each condition. Data are expressed as percentage of wound closure of the original wound width.
Immunofluorescence. Cells (2 Â 10 4 ) were seeded on 8-well glass chamber slides (Nalge Nunc International, Rochester, NY, USA). Before immunostaining, cells were washed with cold PBS, fixed with 2% paraformaldehyde for 20 min and permeabilized for 10 min in PBS/Tween 0.1%. To dilute out of the cell-free tubulin heterodimers cells grown on 8-well glass chamber slides were washed twice in PEM buffer. 37 Then cells were incubated in PEM buffer containing 0.2% Triton X-100 for 1 min at 37 1C and then rinsed and incubated in PEM buffer at 37 1C for 5 min. Cells were then fixed in methanol/acetone (1 : 1). Samples were mounted with Prolong Gold Antifade reagent with DAPI (Invitrogen) and analyzed using an Eclipse TE2000-S microscope with a Â 40, 0.75 NA PanFluor objective (Nikon). Images were acquired with ACT-1 software (Nikon). Confocal microscopy was carried out using a Microradiance 2000 microscopy (Bio-Rad Laboratories, Hercules, CA, USA) equipped with Ar (488 nm) and HeNe (543 nm) lasers. Images were obtained using a Â 40 oil immersion lens 1.4 NA and analyzed using Lasersharp 2000 software. z-stacks of 24 (metaphase) and 19 (anaphase) sections were acquired. Images were processed using ImageJ and Adobe Photoshop.
Cell proliferation and mitotic index. Cells (1 Â 10 3 cells/well) were plated into 48-well plates. At 0, 24, 48 and 72 h, the number of cells was evaluated by Countess automated cell counter (Invitrogen).
For evaluation of the mitotic index, cells were transiently transfected with siRNA. After 48 h, trypsinized cells were fixed by adding 4.5 ml of ice-cold 70% ethanol and incubated at 4 1C. After two washes with PBS/0.03% BSA, cells were incubated with anti-PHH3 (1 : 40) diluted in PBS/0.03% BSA for 1 h at 37 1C followed by incubation with Alexa Fluor 488 goat-anti-rabbit Ab (1 : 1000) in PBS/0.03% BSA for 1 h at room temperature. The mitotic index was reported as the percentage of PHH3-positive cells determined by FACS using the FACSCalibur (Becton Dickinson, San Jose, CA, USA) with CELLQuest software.
MT re-growth assay. Cells (8 Â 10 4 /well) seeded on six-well plates, were transfected with FAK or control siRNA and grown for 24 h. MTs were depolymerized treating the cells with 5 mg/ml nocodazole in complete medium at 37 1C o.n. Cells were washed with complete medium once and incubated at 37 1C. For Me#28 and OAW42 cells, the MT re-growth was allowed for 30 min and 3 h, respectively. Total cell lysates were analyzed by western blotting.
Statistical analyses. GraphPad Prism software (GraphPad Software, San Diego, CA, USA) was used to analyze all data. Differences between mean values were determined by Student's t-test and 2way ANOVA test.
